Morepen Laboratories Ltd. Financials

15:57 Jun 06

Morepen Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
64.12
-0.35 (-0.54%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Morepen Laboratories Ltd. Financials

Morepen Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
64.12
-0.35 (-0.54%)
15:57 Jun 06
Quality
image/svg+xml

52/100
Medium Financial Strength

Valuation
image/svg+xml

39/100
Mid Valuation

Technical

43/100
Technically Neutral

Strength

7

Weakness

1

Opportunity

0

Threats

0

10.20 %

ROE %

6.63 %

ROA %

2.15

EPS

21.10

BVPS

6.51 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
1188.06 1546.83 1417.53 1690.43 1811.58
Operating Expenses +
1069.54 1410.16 1338 1531.81 1637.51
Raw Material
822.13 1059.36 939.26 1060.31 1206.43
Increase Decrease in Cost
-41.58 -10.04 16.48 2.11 -47.12
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
135.59 164.25 154.68 181.47 208.91
Miscellaneous Expenses
561.8 721.05 543.28 641.92 683.79
Operating Profit
118.52 136.67 79.53 158.62 174.07
Other Income
12.07 10.31 6.13 13.97 18.36
Depreciation
30.28 27.64 27.93 33.47 28.98
Interest
1.79 -7.37 1.98 3.71 8.34
Profit before tax and exceptio..
98.51 126.7 55.76 135.42 155.11
Exceptional Items
0 0 0 0 0
PBT
98.51 126.7 55.76 135.42 155.11
Provision for Taxation
1.42 25.02 17.08 38.8 37.09
Net Profit
97.09 101.68 38.68 96.62 118.02
NET Profit after MI
97.09 101.68 38.68 96.16 118.02
EPS
2.16 2.26 0.77 1.88 2.2
Operating Profit Margin (%)
9.98 8.84 5.61 9.38 9.61
Net Profit Margin (%)
8.17 6.57 2.73 5.69 6.51

Morepen Laboratories Ltd. Shareholding

All Data in Percentage (%)

Mar 25 Dec 24 Sep 24 Jun 24 Mar 24
Promoter 35.60 35.60 35.60 38.20 38.20
FII 1.90 2.20 2.10 1.70 1.80
MF 0.00 0.00 0.00 0.00 0.00
Others 1.70 1.70 1.70 2.10 2.20
Shareholder Shares Holding %
Download Our App On: